Post by AstraZeneca

We are aiming to push the boundaries of science in advancing our early oncology pipeline, demonstrated by our abstracts and disclosures at the AACR Annual Meeting in San Diego. These preclinical presentations reflect our Oncology R&D strategy in action, from the assets and platforms we’re building to how we think about earlier intervention and combination approaches as part of our work toward our bold ambition of eliminating cancer as a cause of death. #AACR26